Ophthalmology drug pipeline

AMD, diabetic retinopathy, glaucoma, dry eye, and other ophthalmological therapeutics.

Recent approvals (last 30 days)

No approvals in this window.

Upcoming PDUFA dates (next 6 months)

No upcoming decisions in this window.

Top sponsors

1. Allergan · 57 drugs
2. Bausch & Lomb Incorporated · 34 drugs
3. · 15 drugs
4. Laboratorios Sophia S.A de C.V. · 14 drugs
5. Merck Sharp & Dohme LLC · 12 drugs
6. Aristotle University Of Thessaloniki · 10 drugs
7. Santen Pharmaceutical Co., Ltd. · 10 drugs
8. Santen SAS · 9 drugs
9. Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · 9 drugs
10. Medical University of Vienna · 8 drugs

Key drug classes

• Corticosteroid · 31
• Artificial tear / Ocular lubricant · 30
• Prostaglandin F analog · 25
• Calcineurin inhibitor · 21
• Nonsteroidal anti-inflammatory drug (NSAID) · 20
• Carbonic anhydrase inhibitor · 17
• Topical corticosteroid · 16
• Fluoroquinolone antibiotic · 13
• Artificial tear / ocular lubricant · 11
• Ophthalmic lubricant · 9
• Gene therapy · 9
• VEGF-A inhibitor (monoclonal antibody fragment) · 9
• Prostaglandin F receptor agonist · 8
• Anticholinergic agent / Muscarinic antagonist · 7
• VEGF inhibitor (monoclonal antibody) · 7

Subscribe

Get ophthalmology approvals + PDUFA dates in your RSS reader:

• Ophthalmology RSS feed · Atom · JSON

Other therapeutic areas